Pathogenic

Aberrant Labs · 2026 · $9.99 · Action · deal grade C

• Estimated net residual revenue: $194.4k to $291.5k per month
• Opportunity: $242.9k per month at x1.00 dormancy
• Estimated lifetime owners: 112.2k
• 93%% positive across 3614 reviews · 2901.0 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last build shipped 0 months ago

This case as Markdown · Estimates carry ±30-50%% error per title.